Skip to content

Model IR 1200 Insulin Pump

by Animas Corp. 510(k)

Active United States

510(k) K032257

Overview

The Model IR 1200 Insulin Pump is an external syringe pump designed for subcutaneous insulin delivery. It is classified as an insulin infusion pump and is intended for patients with diabetes mellitus requiring continuous insulin infusion. The device administers insulin via an infusion set, facilitating precise and automated insulin delivery to manage blood glucose levels.

This device is supplied as a reusable medical instrument, intended for use in general hospital settings. It operates outside the MRI environment and requires proper handling and storage as outlined in its instructions. The Model IR 1200 holds an FDA 510(k) clearance under the classification of Class II, with predicate device status based on the Animas IR 1000 Series Insulin Infusion Pump. No sterility or single-use specifications are indicated in the regulatory data.

AI-generated from registry data, 1 Oct 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK032257 Date16 Oct 2003ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

7 recalls · FDA

    • Terminated Z-0836-2013 FDA Class III initiated 17 Dec 2012

    Due to an internal calendar date limit (December 31, 2015) these pumps will cease to operate on January 1, 2016, and will result in a call service alarm that is displayed on the pump display.

    • Terminated Z-0005-2013 FDA Class II initiated 16 Jul 2012

    Wear of the keypad that may lead to damage such as tearing or peeling of the edge of the keypad from the pump.

    • Terminated Z-1678-2011 FDA Unclassified (pre-2012) initiated 25 Feb 2011

    Action is being undertaken to address the occurrence of adverse events associated with leaking cartridges. Firm became aware of this issue through customer complaints from pump users reporting the cartridges were leaking.

    • Terminated Z-2396-2010 FDA Unclassified (pre-2012) initiated 18 Mar 2010

    sensor could be damaged

    • Terminated Z-0293-2009 FDA Unclassified (pre-2012) initiated 4 Aug 2008

    Unintentional rebooting: Pump products exhibit an intermittent loss of power due intermittent loss of contact between battery cap and battery canister resulting in the device resetting. The failure of the battery cap may result in failure of the device to administer insulin therapy which may result in hyperglycemia.

    • Terminated Z-0308-06 FDA Unclassified (pre-2012) initiated 31 Oct 2005

    Pumps were refurbished more than one time for the same failure mode in violation of the company's procedure.

    • Terminated Z-0211-05 FDA Unclassified (pre-2012) initiated 28 Sep 2004

    Suspend mode not functioning properly

Specification

510(k)

510(k) Number
FDA Product Code
LZG
Device Class
Class II
Regulation
21 CFR Part 880.5725
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Other devices from Animas Corp.

See all devices from Animas Corp. →

Questions

  • What is the Animas IR 1200 Insulin Pump used for?

    The Animas IR 1200 Insulin Pump is an external syringe pump intended for subcutaneous insulin delivery. It is specifically designed for patients with diabetes mellitus who require continuous insulin infusion to manage their blood glucose levels. By administering insulin via an infusion set, it provides automated and precise dosing to help maintain stable glucose control.

  • Is the Animas IR 1200 Insulin Pump single-use or reusable?

    The Animas IR 1200 Insulin Pump is supplied as a reusable medical instrument. It is intended for use in general hospital settings, where multiple patients may require insulin infusion therapy over time. Reusability is supported by proper handling, cleaning, and maintenance as outlined in the device’s instructions.

  • What are the key specifications for storage and handling of the Animas IR 1200?

    The Animas IR 1200 must be stored and handled according to the manufacturer’s instructions to ensure safety and functionality. Unlike single-use devices, it requires regular maintenance, including cleaning and inspection, to prevent contamination or malfunctions. Additionally, the device is not intended for use in MRI environments, so proper storage away from magnetic fields is recommended.

  • What regulatory status does the Animas IR 1200 Insulin Pump hold?

    The Animas IR 1200 Insulin Pump holds an FDA 510(k) clearance, classified as a Class II device. This clearance is based on substantial equivalence to the Animas IR 1000 Series Insulin Infusion Pump, meaning it meets the same regulatory standards for safety and performance. The device was reviewed by the FDA’s Orthopaedic and Rehabilitation Devices Advisory Committee (HO) and is approved for use in general hospital settings.

  • Does the Animas IR 1200 come with any sterility guarantees?

    The regulatory data for the Animas IR 1200 Insulin Pump does not specify any sterility requirements or guarantees. Since it is a reusable device, sterility is maintained through proper cleaning and maintenance procedures as directed by the manufacturer. Clinicians should follow the included instructions to ensure the device remains safe for repeated use.